Effect of Acute Exercise on Cognitive Functions and Blood Markers of Brain Plasticity in Regular Chronic Cannabis Users
NCT06081218 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60
Last updated 2026-05-15
Summary
The endocannabinoid system (ECS) is a complex endogenous signaling system made up of transmembrane cannabinoid receptors (CB1 and CB2 receptors), their endogenous lipid-derived ligands (the endocannabinoids - eCBs), and enzymes for ligand biosynthesis and degradation. Interestingly, exercise increase plasma AEA, one of the most famous endocannabinoid. This increase could be involved in exercise-induced neurogenesis and other beneficial exercise adaptations. Chronic cannabis use is associated with alteration of ECS activity. The aim of the study is to compare ECS response to exercise between chronic cannabis users and non-users.
Conditions
- Cannabis User
Interventions
- OTHER
-
activity test
Over 2 weeks, participants have to do a maximal progressive exercise and a 30 min constant exercise at 50% of maximal aerobic power
Sponsors & Collaborators
-
University Hospital, Lille
lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 35 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-05-07
- Primary Completion
- 2029-05-31
- Completion
- 2029-12-31
Countries
- France
Study Locations
More Related Trials
-
Reward and Drug Effects on Mood and Brain Response
NCT04512365 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Activation of the Endocannabinoid System and Cognition
NCT05226351 ·Status: COMPLETED ·Phase: NA
-
Effect of Medical Marijuana on Neurocognition and Escalation of Use
NCT03224468 ·Status: COMPLETED ·Phase: NA
-
N-acetylcysteine for the Treatment of Cannabis Dependence: Working Mechanisms
NCT03221231 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of the Relationship Between Dose-concentration-effect of Delta-9-tetrahydrocannabinol (THC) and the Ability to Drive in Chronic or Occasional Cannabis Users
NCT02061020 ·Status: COMPLETED ·Phase: NA
-
A Study Testing the Effects of Different THC Doses on Psychological and Biological Function
NCT07346690 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition
NCT02404688 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Cannabinoids Effects on the Pain Modulation System
NCT02560545 ·Status: UNKNOWN ·Phase: NA
-
Behavioral Effects of Pregabalin and Cannabis
NCT01511640 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study I
NCT02709954 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Effects of Cannabis Administration Routes on Human Performance and Pharmacokinetics
NCT02177513 ·Status: COMPLETED ·Phase: PHASE1
-
THC Memory & Reward Learning Pilot
NCT05116527 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Dose-response of Cannabis and Driving
NCT03656029 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Sativex(Registered Trademark) and Oral THC on Attention, Affect, Working Memory, Reversal Learning, Physiology and Brain Activation
NCT01037608 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness and Safety of Oil Extracts Medical Cannabis Treatment for Patients With Chronic Pain
NCT04031313 ·Status: UNKNOWN
-
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Sub-Study II
NCT02710097 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Substudy III
NCT02710331 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Assessment of Neural Oscillations in Adult Subjects With Down Syndrome and Typically Developing Subjects in Resting State and While Conducting Cognitive Tasks
NCT04791124 ·Status: UNKNOWN
-
Effect of Cannabis Extract on Acute Radicular Pain and on Analgesic Requirement
NCT04816994 ·Status: RECRUITING ·Phase: PHASE3
-
Neuroprotection by Cannabinoids in Huntington's Disease
NCT01502046 ·Status: COMPLETED ·Phase: PHASE2
-
Effects of Cannabis on Prescription Drug Abuse Liability and Analgesia
NCT03679949 ·Status: COMPLETED ·Phase: PHASE1
-
Delta-THC in Behavioral Disturbances in Dementia
NCT01302340 ·Status: COMPLETED ·Phase: PHASE2
-
Cannabioids as a New Intervention for Amphetamine Dependence
NCT02952196 ·Status: WITHDRAWN ·Phase: PHASE2
-
Cannabinoids, Neural Synchrony, and Information Processing
NCT00708994 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
The Effects of ∆-9-THC and Naloxone in Humans
NCT01591629 ·Status: COMPLETED ·Phase: EARLY_PHASE1